Henrik Lind • 1983 • Nesøya • 12 roles • 7 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
D DANZIG AS	Managing Director/CEO	501,000	1,377,456	100 % directly
H HCL AS	Managing Director/CEO	3,729,516	-147,938	100 % indirectly
M MEDPOINT AS	Managing Director/CEO	12,483,902	312,220	33.33 % indirectly
E EPSYK AS	Managing Director/CEO	2,235,744	333,979	23.75 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
D DANZIG AS	Chairman	501,000	1,377,456	100 % directly
H HCL AS	Chairman	3,729,516	-147,938	100 % indirectly
F FORTFRISK AS	Chairman	353,990	-1,823,516	50.03 % indirectly
N NOVEIDA AS	Chairman	-	-13,008	50 % indirectly
M MEDPOINT AS	Board Member	12,483,902	312,220	33.33 % indirectly
M MEDPOINT AS Closed	Board Member	1,200	555,593	25 % indirectly
E EPSYK AS	Board Member	2,235,744	333,979	23.75 % indirectly
H HENRIK CHRISTER LIND	Holder	-	-	-

Last update: Apr 13, 2023

Related industries1

Health and social
/ Hospital and doctors

Direct relationships3

CT
Christer Torgilstveit Larsen1985
FORTFRISK AS, MEDPOINT AS, MEDPOINT AS, NOVEIDA AS, EPSYK AS
PA
Peder Anker1985
MEDPOINT AS, MEDPOINT AS
LK
Lars Kristian Gullestad1985
MEDPOINT AS

Shares owned by Henrik Lind

Name	Share class	Total operating income	Total equity	Share
D DANZIG AS	Ordinære aksjer	501,000	1,377,456	100 % directly
H HCL AS		3,729,516	-147,938	100 % indirectly
F FORTFRISK AS		353,990	-1,823,516	50.03 % indirectly
N NOVEIDA AS		0	-13,008	50 % indirectly
M MEDPOINT AS		12,483,902	312,220	33.33 % indirectly
M MEDPOINT AS Closed		1,200	555,593	25 % indirectly
E EPSYK AS		2,235,744	333,979	23.75 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025